Overview

Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
To show the superiority of Azathioprine comparing Mesalazine in the prevention of postoperative recurrence in Crohn's Disease.
Phase:
Phase 3
Details
Lead Sponsor:
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Treatments:
Azathioprine
Mesalamine